Panaji, February 4: The Goa Medical College (GMC) on Sunday started using pertuzumab, a modern drug, expanding its treatment protocol for a subset of breast cancer patients, state health minister Vishwajit Rane said. The initiative was launched on World Cancer Day, which is observed on February 4 every year to raise awareness of the disease and encourage its prevention, detection and treatment.

He said the medicine will be used to treat HER2-positive breast cancer patients, who test positive for a protein called human epidermal growth factor receptor 2, and they will get it for free. This protein promotes the growth of cancer cells. In about one of every five breast cancer cases, the cancer cells have extra copies of the gene that makes the HER2 protein, he said. World Cancer Day 2024: Everyday Household Items Plastic Bottles, Tea Bags, Beauty Products and E-Cigarettes Behind Rising Cancer Cases, Say Experts.

“Recognizing the evolving landscape of cancer therapeutics, the medical community at GMC has now incorporated pertuzumab, a second antibody, into the treatment regimen,” Rane told reporters. World Cancer Day 2024 Date, Theme, History and Significance: Know About the International Day That Raises Awareness of Cancer and Encourages Its Prevention, Detection, and Treatment.

He said GMC has been providing care to HER2 positive breast cancer patients, using the antibody trastuzumab in conjunction with chemotherapy. He said pertuzumab-trastuzumab fixed drug combination represents a significant advancement in cancer care.

(This is an unedited and auto-generated story from Syndicated News feed, LatestLY Staff may not have modified or edited the content body)